Lipid nanoparticles (LNP) induce activation and maturation of antigen presenting cells in young and aged individuals
Jennifer Connors(Drexel University), Elias K. Haddad(Drexel University), Matthew R. Bell(Drexel University), Paulo J.C. Lin(University of British Columbia), Kenneth M. Kim(Drexel University), Jennifer Marcy(Drexel University), David Joyner(Drexel University), Ying K. Tam(Arbutus Biopharma (Canada)), Drew Weissman(California University of Pennsylvania), Mohamad‐Gabriel Alameh(Children's Hospital of Philadelphia), Gina Cusimano(Drexel University), Michele A. Kutzler(Drexel University), Bhavani Taramangalam(Drexel University), Nathan Mege(Reading Hospital)
Cited by 110
Related Papers
mRNA vaccines — a new era in vaccinology
|Nature Reviews Drug Discovery|2018|4.4k
Rational design of cationic lipids for siRNA delivery
|Nature Biotechnology|2010|1.8k
The Onpattro story and the clinical translation of nanomedicines containing nucleic acid-based drugs
|Nature Nanotechnology|2019|1.6k
Maximizing the Potency of siRNA Lipid Nanoparticles for Hepatic Gene Silencing In Vivo**
|Angewandte Chemie International Edition|2012|1.2k
CAR T Cells Produced in vivo to Treat Cardiac Injury
|HAL (Le Centre pour la Communication Scientifique Directe)|2023|940